BRISTOL MYERS SQUIBB CO Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bristol Myers Squibb Co quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2010 to Q4 2024.
  • Bristol Myers Squibb Co Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $120M, a 5.51% decline year-over-year.
  • Bristol Myers Squibb Co Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $507M, a 2.12% decline year-over-year.
  • Bristol Myers Squibb Co annual Share-based Payment Arrangement, Expense for 2024 was $507M, a 2.12% decline from 2023.
  • Bristol Myers Squibb Co annual Share-based Payment Arrangement, Expense for 2023 was $518M, a 13.3% increase from 2022.
  • Bristol Myers Squibb Co annual Share-based Payment Arrangement, Expense for 2022 was $457M, a 21.6% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $507M $120M -$7M -5.51% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-12
Q3 2024 $514M $129M -$3M -2.27% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $517M $125M -$12M -8.76% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-26
Q1 2024 $529M $133M +$11M +9.02% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $518M $127M +$8M +6.72% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-12
Q3 2023 $510M $132M +$17M +14.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $493M $137M +$21M +18.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-26
Q1 2023 $472M $122M +$15M +14% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $457M $119M -$14M -10.5% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-12
Q3 2022 $471M $115M -$27M -19% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $498M $116M -$41M -26.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $539M $107M -$44M -29.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 $583M $133M -$38M -22.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-13
Q3 2021 $621M $142M -$43M -23.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 $664M $157M -$56M -26.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 $720M $151M -$59M -28.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $779M $171M -$113M -39.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-14
Q3 2020 $892M $185M +$129M +230% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-27
Q2 2020 $763M $213M +$165M +344% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 $598M $210M +$157M +296% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $441M $284M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-09
Q3 2019 $56M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $48M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $53M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2016 $205M $56M -$3M -5.09% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-25
Q3 2016 $208M $48M -$15M -23.8% Jul 1, 2016 Sep 30, 2016 10-Q 2016-10-27
Q2 2016 $223M $54M -$5M -8.48% Apr 1, 2016 Jun 30, 2016 10-Q 2016-07-28
Q1 2016 $228M $47M -$7M -13% Jan 1, 2016 Mar 31, 2016 10-Q 2016-04-28
Q4 2015 $235M $59M -$7M -10.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-13
Q3 2015 $242M $63M +$15M +31.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-27
Q2 2015 $227M $59M +$9M +18% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-28
Q1 2015 $218M $54M +$5M +10.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-28
Q4 2014 $213M $66M +$15M +29.4% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-21
Q3 2014 $198M $48M +$3M +6.67% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
Q2 2014 $195M $50M +$4M +8.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-23
Q1 2014 $191M $49M $0 0% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q4 2013 $191M $51M +$5M +10.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-12
Q3 2013 $186M $45M -$75M -62.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-24
Q2 2013 $261M $46M +$6M +15% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-24
Q1 2013 $255M $49M +$7M +16.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q4 2012 $248M $46M +$5M +12.2% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-13
Q3 2012 $243M $120M +$81M +208% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-23
Q2 2012 $162M $40M -$3M -6.98% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-25
Q1 2012 $165M $42M +$4M +10.5% Jan 1, 2012 Mar 31, 2012 10-Q 2012-04-26
Q4 2011 $161M $41M -$9M -18% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-14
Q3 2011 $170M $39M -$8M -17% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-24
Q2 2011 $178M $43M -$6M -12.2% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-25
Q1 2011 $184M $38M -$9M -19.1% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q4 2010 $193M $50M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-15
Q3 2010 $47M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-27
Q2 2010 $49M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
Q1 2010 $47M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.